On June 1, R. Thomas Zoeller, PhD, co-chair of the Society’s EU and Global EDC Task Forces presented during the European Commission (EC) Conference on Endocrine Disruptors: Criteria for Identification and Related Impacts and told the European Commission that current approaches to identify EDCs are not effective because they do not take into account critical...
On April 29, the Society co-hosted a roundtable with Merck to discuss the current hypoglycemia landscape and to delve deeper into policy priorities that were identified at our diabetes policy summit last September. The roundtable featured key officials from professional societies, patient advocates, quality improvement organizations, and the federal government, including NIDDK, CDC, and Veteran’s...
Meaningful Use Rules Outline Changes to the Program for 2015 and Beyond
The CMS released a Notice of Proposed Rule Making (NPRM) on March 20, which outlines the requirements for Stage 3 Meaningful Use for eligible professionals (EPs), eligible hospitals, and critical access hospitals in the EHR Incentive Programs. The CMS believes that the provisions in the rule will provide more flexibility to EPs by: Establishing a...
The spring is always hectic in Washington, D.C. It is the time of year when tourists flock to D.C. for cherry blossoms, school trips take in the historic sites, and Congress is hard at work on several legislative deadlines, including the federal budget, appropriations, and repeal of Medicare’s flawed physician payment system. On March 25,...
Congress Passes Two Society Policy Priorities, Repeals SGR, and Renews SDP On April 14, the U.S. Senate permanently repealed the flawed Medicare formula known as the SGR in an overwhelming 92-8 vote. The action came just hours before a 21% cut to Medicare reimbursement was slated to take effect and follows the passage of companion...
Society Advocates for Diabetes Prevention, Research, Treatment, & Coverage Legislation As Congress moves forward with its health agenda, the Endocrine Society has a number of priorities for diabetes prevention, treatment, and research legislation under consideration. These priorities include funding for the National Diabetes Prevention Program (NDPP), renewal of the Special Diabetes Program (SDP), and Medicare...
In addition to funding for the NDPP, the SDP funding is scheduled to expire on September 30, 2015, if Congress fails to act. The SDP was created in 1997 to advance research for type 1 diabetes and to address the disproportionate burden of type 2 diabetes on American Indians and Alaska Natives (AIAN). Through this...
The Society is a leading advocate for funding for the NDPP, a program that uses lifestyle intervention to prevent or delay the onset of diabetes among individuals with prediabetes. The Society has advocated for increased funding for the program on Capitol Hill and with U.S. Surgeon General Vivek Murthy. With support from the Society, the...
Endocrinology Advocacy
Not all topics of relevance to endocrinologists are about specific conditions and diseases. Sometimes, doctors need information about changes in the medical field or the field of endocrinology. Changes to medical insurance legislation, drug trial regulations and even patient privacy legislation all impact a practitioner’s way of doing business and practicing medicine. Yet keeping track of these details is not always easy. That’s why Endocrine News has organized articles and news pieces on these topics into this advocacy page. Here, practitioners can find the information gathered by the Endocrine Society, a leading endocrinology advocacy organization, conveniently in one location.
Important Advocacy Information From the Endocrine Society
As an endocrinology advocacy organization, the Endocrine Society is constantly working to advocate for endocrinologists and their patients, both in the government and in various research centers across the country. Here on Endocrine News, you can stay informed about these efforts and their results, so you are well aware of what changes may be coming that affect your practice. This is an invaluable resource for doctors who wish to spend their time focusing on their patients, rather than advocating for their practices, but also wish to stay informed about what is happening in the field.
Both Clinical and Research Advocacy Information
On the Advocacy page, Endocrine News provides advocacy information relevant to both those in the research field and those practicing on a clinical level. Stay up to date with the activities of the Endocrine Society, learn more about the legislation that affects your work, and see highlights of leading researchers who are pioneering not only advances in the practice but also advocacy for endocrinology as a field. By utilizing the resources on the Advocacy page, you will be better equipped to meet the needs of your patients while staying abreast on the changes affecting the industry.
